Sarah Cannon Tennessee Oncology — Nashville, Tennessee

Sarah Cannon Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon Tennessee Oncology has participated in 6 clinical trials with 4 currently active.

Therapeutic areas: Locally Advanced Solid Tumor, Non Small Cell Lung Cancer, Solid Tumors, Adult.

Sponsors: Tango Therapeutics, Inc., Razor Genomics, Infinity Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Tennessee Oncology?

Sarah Cannon Tennessee Oncology has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Tennessee Oncology conducted?

Sarah Cannon Tennessee Oncology has 6 clinical trials on record, with 4 currently active. Their work covers Locally Advanced Solid Tumor, Non Small Cell Lung Cancer, Solid Tumors, Adult.

Is Sarah Cannon Tennessee Oncology accredited by Crixeo Health?

Yes — Sarah Cannon Tennessee Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sarah Cannon Tennessee Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.